ETH Zurich is currently ranked as the 4th best European and the 9th best university worldwide. Its mission is to educate engineers and scientists, serve as a national center of excellence in science and technology and provide a hub for interaction between the scientific community and industry. The Institute of Chemical and Bioengineering involved in this project is home to over 250 scientists and engineers working on a broad range of topics including, chemical aspects of energy, heterogeneous catalysis, colloid engineering, biotechnology, bioengineering and microfluidics.


Established in 1855 as the Federal Polytechnical School, ETH Zurich has, from the outset, been a national centre for education with international appeal, attracting talent from all over the world. The successful combination of a cosmopolitan outlook with national roots made the young educational institution one of the driving forces behind industrialisation in Switzerland: it brought the necessary expertise into the country, trained technical specialists and helped set up groundbreaking national infrastructures.

ETH Zurich was given its present name, Swiss Federal Institute of Technology (Eidgenössische Technische Hochschule), in 1911. Over the decades that followed, it entered into solid partnerships with the state and with industry and invested increasingly in both applied and fundamental research, which were gaining in importance in relation to education. The university grew steadily and in 1961 it embarked on the first stage of constructing its second site on the Hönggerberg, on the outskirts of Zurich.

In more recent times, global developments such as computer-assisted data processing and the far-reaching consequences of globalisation have placed ever-increasing demands on universities. ETH Zurich reacts to these new challenges by creating flexible organisational structures: new research units and programmes have emerged and the research itself is becoming more and more integrated and interdisciplinary.

The long-standing tradition of ETH Zurich, combined with its ability constantly to adapt to new requirements, have brought great success to the university. Today, it ranks among the world’s leading universities of science and technology.

The ETH Institute of Chemical and Bioengineering as the internationally recognized leader in this field will contribute through development of novel technologies for combinatorial screening, development, and application of novel microfluidic platforms for high-throughput imaging cytometry.

The project will provide this partner with interesting biological, biochemical and medical problems that will require application of high- throughput screening methods in nano- or femto-littres and development of advanced lob- on-chip automated platforms.